Influence of atorvastatin in short-term renal function and long-term cardiovascular events in patients with high risk for CIN

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10001606

Enrollment

Unknown

Registered

2010-11-25

Start date

2011-06-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contrast-InducedNephropathy

Interventions

1:atorvastatin 80mg

2:atorvastatin 40mg

3:atorvastatin 20mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PCI and the CIN risk score >=6

Exclusion criteria

Exclusion criteria: 1. BMI<18; 2. Acute renal failure, endstage renal disease requiring dialysis; 3. Alanine transaminase elevation; 4. Pregnancy or lactation; 5. History of hypersensitivity to statin; 6. Tumor or connective tissue disease.

Design outcomes

Primary

Measure	Time frame
alpha-MG, mALB, TRF, Cr;CysC;hs-CRP, Fib;	—

Secondary

Measure	Time frame
TNI, CK-M;	—

Countries

China

Contacts

Public ContactJinzi Su

sujinzi1@yahoo.com.cn+86 13706948600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026